Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap41.66B
Enterprise Value44.27B
P/E Ratio25.9
PEG Ratio-0.65
Price/Sales Ratio4.74
Price/Book Ratio0.97
Enterprise/Revenue5.06
Enterprise/EBITDA23.27

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.18
Operating Margin0.19
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue7.35B
Revenue/Share1
Gross Profit2.69B
EBITDA1.84B
Net Income1.58B
Diluted EPS0.24

Balance Sheet

Total Cash2.44B
Total Cash/Share0.37
Total Debt3.58B
Total Debt/Equity0.11
Current Ratio4.49
Book Value Per Share4.92

Price History

52-Week Change-29.21
52-Week High6.97
52-Week Low4.18
Moving Average 50 Days4.99
Moving Average 200 Days5.43

Statistics

Average Volume49.5M
Shares Outstanding6.59B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield1.02
Payout Ratio0.14
Last Split Factor9:5
Last Split DateSeptember 28, 2016
AD